Study reveals a promising approach to developing universal influenza vaccine

FHS
July 19, 2024
4:36 pm

New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine -; a so-called “one and done” vaccine that confers lifetime immunity against an evolving virus.

Biotech execs vie for a share of obesity drug boom: ‘It’s the early innings’

Pharma giants Novo Nordisk and Eli Lilly might’ve led the way into a new era of obesity drugs, but they’re not going to own it,

September 7, 2023

HHS’s proposed rule pays lip service to addressing the climate crisis, the greatest threat to human health

In April, the U.S. Department of Health and Human Services, the world’s most powerful health care agency — responsible for overseeing the largest industry in

May 20, 2024

Adapted CAR-T Therapy Shows Promise in Myasthenia Gravis

The first study to use an RNA-based chimeric antigen receptor T-cell (rCAR-T) therapy in autoimmune disease showed people with generalized myasthenia gravis tolerated the treatment

July 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.